Moody National Bank Trust Division Grows Position in Evolent Health, Inc. (NYSE:EVH)

Moody National Bank Trust Division raised its position in shares of Evolent Health, Inc. (NYSE:EVH) by 4.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 176,653 shares of the technology company’s stock after acquiring an additional 7,450 shares during the period. Moody National Bank Trust Division owned approximately 0.15% of Evolent Health worth $1,987,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in EVH. Royce & Associates LP acquired a new stake in shares of Evolent Health in the third quarter worth $7,070,000. Foundry Partners LLC purchased a new stake in shares of Evolent Health during the third quarter valued at approximately $10,042,000. Harbor Capital Advisors Inc. increased its stake in Evolent Health by 140.0% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 422,421 shares of the technology company’s stock worth $11,946,000 after buying an additional 246,400 shares during the period. Bellevue Group AG lifted its holdings in Evolent Health by 59.9% in the 3rd quarter. Bellevue Group AG now owns 2,670,050 shares of the technology company’s stock worth $75,509,000 after buying an additional 1,000,215 shares in the last quarter. Finally, Engaged Capital LLC boosted its holdings in Evolent Health by 26.1% in the second quarter. Engaged Capital LLC now owns 4,111,458 shares of the technology company’s stock valued at $78,611,000 after purchasing an additional 850,000 shares during the last quarter.

Evolent Health Trading Down 1.6 %

Shares of Evolent Health stock traded down $0.20 during trading on Monday, hitting $12.34. The stock had a trading volume of 489,018 shares, compared to its average volume of 1,421,437. Evolent Health, Inc. has a 1 year low of $10.53 and a 1 year high of $35.00. The stock has a 50 day simple moving average of $12.91 and a 200 day simple moving average of $21.03. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $1.44 billion, a PE ratio of -13.56 and a beta of 1.45.

Analyst Upgrades and Downgrades

A number of research analysts have commented on EVH shares. JMP Securities reduced their price objective on shares of Evolent Health from $27.00 to $18.00 and set a “market outperform” rating on the stock in a research note on Friday. Barclays dropped their price target on Evolent Health from $39.00 to $19.00 and set an “overweight” rating on the stock in a research report on Monday, November 11th. Needham & Company LLC began coverage on shares of Evolent Health in a report on Friday. They issued a “buy” rating and a $15.00 price target for the company. Royal Bank of Canada reaffirmed an “outperform” rating and set a $20.00 target price on shares of Evolent Health in a report on Tuesday, November 12th. Finally, Stephens cut Evolent Health from an “overweight” rating to an “equal weight” rating and cut their target price for the company from $38.00 to $16.00 in a research note on Friday, November 8th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $22.83.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.